INEN

What INEN does

Instituto Nacional de Enfermedades Neoplásicas (INEN) is Peru's national reference center for the prevention, diagnosis, treatment and epidemiological surveillance of cancer. Founded on December 4, 1939 as Instituto Nacional del Cáncer and redesignated INEN in 1952, the institute operates as an Organismo Público Descentralizado under the Ministry of Health (MINSA), with its own legal personality and administrative, budgetary, financial and normative autonomy granted by Law No. 28748 (May 30, 2006) and reinforced as an Organismo Público Ejecutor by Supreme Decree No. 034-2008-PCM. Headquartered at Av. Angamos Este 2520 in Surquillo, Lima, INEN runs a tertiary-level service portfolio organized across specialized departments for medical oncology, surgical oncology (with sub-departments for head/neck, thoracic, abdominal, gynecological, urological, neurosurgery and breast/soft tissue), radiotherapy (including a cobalt unit and the first linear accelerator installed in South America), nuclear medicine, pediatric oncology (with the first pediatric ICU in the national public sector), diagnostic and treatment support (pathology, molecular biology, genetics, blood bank, tumor bank, medical imaging including Latin America's most modern MRI), telemedicine, and a Health Technology Assessment Unit (UFETS) that maintains a national ETS repository. The institute also operates a National Cancer Registry for Lima Metropolitana, a medical residency program established in 1939, and the cancer prevention programs (Semana Perú Contra el Cáncer, Preventorio Radial, Preventorios Contra el Cáncer).

INEN reaches patients through three physical anchors — its main Lima facility plus two wholly-owned regional subsidiaries, IREN Norte (Trujillo, inaugurated 2007) and IREN Sur (Arequipa, inaugurated 2007) — supported by a national referral pipeline from MINSA hospitals and a growing telemedicine channel. The institution has secured notable accreditations and milestones, including the first linear accelerator in South America (1960s), OAS recognition of its oncology teaching program (1960), and the first ISO 9001:2015 certification awarded to a Peruvian public-sector IPRESS for its pathology department (covering clinical laboratory analysis, molecular biology, genetics, anatomical pathology, blood bank and tumor bank). Research output is anchored by 500+ approved clinical research protocols since 2004, digital cervical cytology screening using AI-based computer vision deployed within the UFETS rapid-review workflow, and partnerships spanning ESGO, PAHO/WHO (Global Initiative for Childhood Cancer), RedETSA, CONCYTEC/World Bank, and three Peruvian universities.

INEN's revenue model is that of a public-sector healthcare provider funded primarily through annual MINSA budgetary allocations, supplemented by project-based international cooperation (CONCYTEC, World Bank) and capital investments such as the Laser Microdissection Microscope. Services are delivered under an institutional tariff schedule to a base that includes patients covered by SIS public health insurance, referrals from regional facilities, and direct presentations. Customer-facing activities are supplemented by structured prevention and education programs (64,000+ annual cancer-prevention counseling sessions; Peru Against Cancer Week; the Preventorio Radial radio show launched 2006 on Radio Libertad), producing a public-health distribution footprint rather than a commercial marketing channel.

Name

INEN

Legal name

Instituto Nacional de Enfermedades Neoplásicas

Website

https://portal.inen.sld.pe

Company type

Private

Founded year

1939

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Instituto Nacional de Enfermedades Neoplásicas (INEN) is Peru's public national reference center for cancer care, providing comprehensive oncology services — prevention, surgery, radiotherapy, chemotherapy, nuclear medicine, diagnostics and research — from its main facility in Lima and regional IREN branches, funded by MINSA allocations.

Ownership category

akta.pro rank

Product category

Oncology Healthcare Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), Medical and Diagnostic Laboratories (62151)

SIC

Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM), Oncology Telemedicine Platforms (HLALAGAH)

Keywords

• Oncology treatment services
• Cancer prevention programs
• Radiation therapy services
• Medical oncology care
• Surgical oncology services

Headquarters

HQ city

Surquillo

HQ country

Peru

HQ region

Latin America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Public Healthcare Services: INEN is a decentralized public organism (Organismo Público Descentralizado) under the Ministry of Health (MINSA), funded primarily through government budgetary allocations from the Peruvian state. Services are provided to patients including those covered by public health insurance (SIS) and other mechanisms.
2. Institutional Budget: Annual government budget allocation through MINSA, with additional funding from projects and international cooperation (CONCYTEC/Banco Mundial)

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

INEN operates as a comprehensive oncology treatment center providing cancer surgery, radiotherapy (linear accelerator and cobalt unit), medical oncology, nuclear medicine, diagnostic imaging, pathology, and laboratory services to Peruvian cancer patients. As Peru's national reference center, it also delivers cancer prevention programs, pediatric oncology, telemedicine services, health technology assessments, medical residency training, and maintains a national cancer registry for epidemiological surveillance.

Product overview

INEN (Instituto Nacional de Enfermedades Neoplásicas) is Peru's national cancer institute offering comprehensive oncology services through an integrated healthcare delivery model. The institution operates as a decentralized public organism under the Ministry of Health, providing cancer control, medical oncology, surgical oncology (with specialized departments for head/neck, thoracic, abdominal, gynecological, urological, neurosurgery, and breast/soft tissue), radiation therapy, nuclear medicine, diagnostic support services, and pediatric oncology. The institute also operates a Health Technology Assessment Unit that evaluates medical technologies and maintains a national ETS repository. Additional services include telehealth/telemedicine, health promotion programs, medical education through residency programs, and population-based cancer registries for epidemiological surveillance. INEN serves as the national reference center for cancer treatment and prevention in Peru.

Differentiator

Problem solved

Functional benefit

Brands

• IRENES (Institutos Regionales de Enfermedades Neoplásicas): Regional cancer institutes established as part of the decentralization process serving different regions of Peru
• Preventorio Contra el Cáncer
• INEN

Products and services

• Control del Cáncer (Cancer Control Program) Cancer control programs including prevention, early detection, and screening services for the Peruvian population.
• Medicina Oncológica (Medical Oncology) Medical oncology services including chemotherapy, targeted therapies, and cancer treatment using pharmacological interventions for adult oncology patients.
• Cirugía Oncológica (Surgical Oncology) Surgical oncology services including specialized departments for head and neck, thoracic, abdominal, gynecological, urological, neurosurgery, and breast/soft tissue surgeries.
• Radioterapia (Radiotherapy) Radiation therapy services using modern equipment for cancer treatment including cobalt therapy and linear accelerator (first installed in South America).
• Apoyo al Diagnóstico y Tratamiento (Diagnostic and Treatment Support) Diagnostic and treatment support services including laboratory analysis, clinical pathology, molecular biology, genetics, blood bank, tumor bank, and medical imaging.
• Telesalud y Telemedicina INEN Telehealth and telemedicine services enabling remote patient consultations and medical guidance for oncology patients.
• Departamento de Patología (Pathology Department) Pathology department providing clinical laboratory analysis, molecular biology, genetics, anatomical pathology, blood bank, and tumor bank services. First public health institution in Peru certified with ISO 9001:2015.
• Oncología Pediátrica (Pediatric Oncology) Pediatric oncology services for the diagnosis and treatment of childhood cancers, including the first dedicated pediatric intensive care unit in the national public sector.
• Medicina Nuclear (Nuclear Medicine) Nuclear medicine services for cancer diagnosis and treatment including PET scans and radiopharmaceutical therapies.
• Residentado Médico (Medical Residency Program) Medical residency program for specialized training in oncology for graduate physicians, established in 1939 and recognized internationally by OAS and ESGO.
• Registro de Cáncer en Lima Metropolitana (Cancer Registry) Cancer registry providing epidemiological data on cancer incidence and mortality in Lima Metropolitan area, published by the Centro de Investigación en Cáncer 'Maes Heller' since 1998.
• Unidad Funcional de Evaluación de Tecnologías Sanitarias (HTA Unit) Health technology assessment unit conducting rapid reviews and evaluations of medical technologies, drugs, and procedures for oncology use, with membership in RedETSA.
• AI-based Cervical Cytology Screening AI-based analysis of digital cervical cytology images for cervical cancer screening using a digital scanner with artificial intelligence for cervicovaginal cytology interpretation.

Quantifiable outcome

• First public IPRESS with ISO 9001:2015 certification
• +3 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature8 records

Partnerships

Eight partnerships are on record, tiered core, minor and major.

• European Society of Gynecological Oncology (ESGO)coreStrategic or Co-development Partner · 21 February 2024ESGO provided international accreditation for the cervical cancer surgical workshop hosted by INEN. The partnership facilitated collaboration between 10 expert gynecological oncologists from Latin America and Europe for live surgeries, clinical case discussions, and surgical technique training over 4 days.
• Sociedad Peruana de CancerologíacoreStrategic or Co-development Partner · 21 February 2024Local co-organizer of the international cervical cancer workshop alongside ESGO and INEN, combining international expertise with national oncology professional society support.
• CPN RadiominorStrategic or Co-development Partner · 1 January 2008Partnership for 'Prevenir es Vivir' (Prevention is Living) educational radio program broadcast on 90.5 FM frequency.
• Radio LibertadminorStrategic or Co-development Partner · 1 January 2006Strategic alliance for 'Preventorio Radial' (Radial Prevention Program), the first radio program specialized in cancer prevention, broadcast every Wednesday on 820 AM frequency.
• Universidad Peruana Cayetano Heredia, Universidad Nacional Mayor de San Marcos, Universidad Federico VillarrealcoreStrategic or Co-development Partner · 1 January 1965Educational partnership agreements for pre and postgraduate training and research activities in oncology, established to develop specialized oncology human resources.
• ALINEN (Volunteer Association)coreOthersVolunteer organization providing support services to INEN patients including assistance during treatment and patient care support.
• Fundación Peruana de CáncercoreStrategic or Co-development PartnerNon-profit foundation that donated the land for INEN's current facility in Surquillo district and continues supporting cancer patients.
• Pan American Health Organization (PAHO/WHO)majorStrategic or Co-development PartnerInternational partner participating in global cancer initiatives including the Global Initiative for Childhood Cancer in Peru.

Scale indicators9 records

Recent moves11 records

Expansion highlights6 records

Others

• Hospital Italiano de Buenos Aires: Large Argentine academic hospital with a strong oncology service line and research/teaching programs. Comparable in its academic-hospital role and oncology service breadth, though operating as a private non-profit community hospital rather than a national reference center.

Broad incumbents

• Institut Gustave Roussy: Leading European comprehensive cancer center combining treatment, research, and teaching. Comparable as a national/regional reference cancer center; differs in European reimbursement and private-public mix.
• European Institute of Oncology (IEO): Italian specialty oncology hospital focused on research-driven cancer treatment. Comparable as a single-specialty comprehensive cancer center with academic and training programs; differs by funding model and European regulatory context.
• Memorial Sloan Kettering Cancer Center: Premier US specialty cancer hospital with full continuum of oncologic care plus research. Comparable in service scope and academic-mission profile; differentiated by scale, private funding, and US reimbursement dynamics.
• MD Anderson Cancer Center: Global benchmark for specialty oncology hospitals. Comparable as a comprehensive cancer center spanning surgery, radiotherapy, research, and training — though operating at far greater scale and as a private US academic medical center.

Regional players

• Instituto Oncológico Nacional (Panama): Panama's national cancer hospital under the Ministry of Health. Comparable as a public national specialty oncology hospital in Latin America, though smaller in scale and operating in a different country market.

Direct peers

• Hospital de Amor (formerly Hospital de Câncer de Barretos): Large Brazilian oncology specialty hospital system focused on prevention, treatment, and research. Comparable as a high-volume specialty cancer provider with international training programs, though operating under a non-profit/private philanthropic model rather than public organism.
• Instituto Nacional de Cancerología (Colombia): Colombia's national cancer reference institution — a public specialty hospital under the Ministry of Health with the same mandate (prevention, treatment, research, training) as INEN. Closest functional twin in Latin America.
• INCA - Instituto Nacional de Câncer (Brazil): Brazil's federal cancer institute under the Ministry of Health, responsible for national cancer policy, registries, and reference treatment. Operates a similar decentralized model with regional units and is INEN's largest direct peer in scale.

Emerging players

• Karolinska Comprehensive Cancer Centre: Sweden's university-affiliated comprehensive cancer center embedded in the public Karolinska University Hospital. Comparable as a publicly funded academic oncology reference center; smaller geographic footprint than INEN's national mandate.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/INEN_Peru
• YouTubeyoutube.com/channel/UC6o_9n7Yoq6hx2FBlW9Z6Zg
• Facebookfacebook.com/inenneoplasicas
• LinkedInlinkedin.com/company/instituto-nacional-de-enfermedades-neopl%C3%A1sicas-inen
• Instagraminstagram.com/inenperu

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about INEN